Centene 3Q 2026: Revenue $50.6B, Net income $(71)M, EPS $(0.14) — 10-Q Summary
Centene reported 3Q 2026 revenue of $50.6B, up 2% YoY, with a net loss of $71M and EPS of $(0.14). Medicaid and Medicare drove growth, while membership declined 8% YoY to 25.7M. California's UIS transition may reduce membership from 2027.
How this was made
The 30-second read
Why it matters
The earnings release may drive short‑term volatility in CNC as investors weigh the loss against revenue growth and membership trends.
Market read
Centene's earnings are a primary catalyst for its stock and may influence broader managed‑care sector sentiment.
What to watch
Potential impact of California's fee‑for‑service transition and upcoming Medicaid awards in Nevada and Illinois.
Background
Centene's Q3 2026 filing provides the latest financial snapshot, including membership changes and Medicaid dynamics.
Ticker impact
Centene disclosed its Q3 2026 results with $50.6B revenue and a $71M loss, the first public release of these numbers.
likely modest pressure as investors price the unexpected loss despite revenue beat
The report shows a small loss after a prior quarter loss, but revenue rose 2%; market may view the loss as a concern while noting top‑line strength.
Market effects
Highlights Medicaid and Medicare revenue trends for health‑care insurers.
May affect U.S. managed‑care market sentiment.
Limited to U.S. health‑care sector.
Counterpoint
The loss could be a temporary blip; focus on revenue growth and Medicaid rate increases.
Key entities
- companyCentene Corp.
U.S. health‑care insurer reporting Q3 2026 results.
